Myopia Control: a Comparison Study Between Atropine and MiSight
NCT: NCT05815784 · ACTIVE_NOT_RECRUITING
Brief Summary
This research project aims to provide additional knowledge of pharmacological and optical methods of myopia control and to gain a better understanding of the biometry of the pediatric eye, which contributes to the onset and progression of myopia. As a result, this study will improving our best practices for myopia control in pediatric patients.
Frequently Asked Questions
What is Myopia Control: a Comparison Study Between Atropine and MiSight?
Myopia Control: a Comparison Study Between Atropine and MiSight is a clinical trial registered under NCT05815784. Current status: ACTIVE_NOT_RECRUITING.
What is the status of NCT05815784?
The current status of NCT05815784 (Myopia Control: a Comparison Study Between Atropine and MiSight) is: ACTIVE_NOT_RECRUITING.
When did Myopia Control: a Comparison Study Between Atropine and MiSight start?
Myopia Control: a Comparison Study Between Atropine and MiSight started on 2023-05-02.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.